Page last updated: 2024-08-26

fibrinogen and Pulmonary Disease, Chronic Obstructive

fibrinogen has been researched along with Pulmonary Disease, Chronic Obstructive in 92 studies

Research

Studies (92)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's22 (23.91)29.6817
2010's57 (61.96)24.3611
2020's13 (14.13)2.80

Authors

AuthorsStudies
Antony, VB; Athar, M; Bae, S; Dransfield, MT; Dsouza, KG; Kim, YI; Li, FJ; Liu, RM; Singh, P; Stephens, CT; Surolia, R; Wang, Z1
Araújo, AS; Figueiredo, MR; Lomonaco, I; Lundgren, F; Mesquita, R; Pereira, EDB1
Cao, Z; Luo, Z; Ma, Y; Sun, W; Wang, J; Zhang, L1
Gong, L; He, D; He, Q; Huang, D; Liang, Z; Shi, Y; Wang, W; Wu, Z; Yang, L; Yao, R; Zhang, Z1
Badr, MY; Bahey, MG; Elkholy, AA; Mohamed, EA; Reda, AM; Shoeib, SM1
Hu, X; Li, P; Xu, J; Zheng, H1
Sin, DD1
Gao, Y; Han, M; Li, T; Li, X; Liu, Y; Wang, L; Wang, X; Wu, D; Xu, Y; Zhu, Y1
Gibbons, LP; Holden, NS; Jenkins, AR; Jones, AW1
Barrecheguren, M; Esquinas, C; Gava, G; Loeb, E; Miravitlles, M; Núñez, A; Pirina, P; Sarasate, M1
Čepelak, I; Hlapčić, I; Popović-Grle, S; Rako, I; Rogić, D; Rumora, L1
He, D; Liu, S; Niu, W; Wang, K; Wang, Y; Yang, T; Zhang, Q; Zhang, Z; Zhou, B1
Holden, NS; Jenkins, AR; Jones, AW1
Criner, GJ; Dransfield, MT; Halpin, DMG; Han, MK; Lange, P; Lettis, S; Lipson, DA; Lomas, D; Mannino, D; Martin, N; Martinez, FJ; Miller, BE; Singh, D; Wise, R; Zhu, CQ1
Andrijevic, I; Andrijevic, L; Jokic, D; Milutinov, S; Vukoja, M1
Adachi, O; Akiyama, M; Hayatsu, Y; Hosoyama, K; Kawamoto, S; Kawatsu, S; Kumagai, K; Masaki, N; Motoyoshi, N; Saiki, Y; Sakatsume, K; Sakuma, K; Sasaki, K; Suzuki, Y; Takahara, S; Yoshioka, I1
Cheriyan, J; Cockcroft, JR; Fisk, M; Forman, J; Fuld, J; Hopkinson, NS; Lomas, DA; Mäki-Petäjä, KM; McEniery, CM; Mohan, D; Polkey, MI; Rudd, JHF; Tal-Singer, R; Wilkinson, IB1
Allinder, M; Bolton, CE; Calverley, PMA; Cheriyan, J; Cockcroft, JR; Fisk, M; Forman, JR; Fuld, J; Gale, NS; Lomas, DA; MacNee, W; Marchong, M; McEniery, CM; Miller, BE; Mohan, D; Nagarajan, S; Polkey, MI; Tal-Singer, R; Wilkinson, IB1
Karsdal, MA; Langholm, LL; Leeming, DJ; Manon-Jensen, T; Miller, BE; Rønnow, SR; Sand, JMB; Tal-Singer, R; Vestbo, J1
Anderson, JA; Brook, R; Calverley, P; Celli, BR; Cowans, NJ; Crim, C; Dixon, I; Kim, V; Martinez, FJ; Morris, A; Newby, DE; Vestbo, J; Yates, J1
Hyun, DG; Lee, JS; Lee, SD; Lee, SW; Oh, YM1
Park, SY; Yoo, KH1
Cazzola, M; Ora, J; Puxeddu, E; Rogliani, P1
Ancochea, J; Duran-Tauleria, E; García-Rio, F; Miravitlles, M; Muñoz, L; Sánchez, G; Sobradillo, V; Soriano, JB1
Akkermans, R; Heijdra, Y; Lenders, JW; Scheepers, PT; Schermer, TR; van Dijk, WD; Weel, Cv1
Casaburi, R; Celli, B; Crapo, J; Criner, G; Croxton, T; Gaw, A; Jones, P; Kline-Leidy, N; Lomas, DA; Merrill, D; Polkey, M; Rennard, S; Sciurba, F; Stockley, R; Tal-Singer, R; Turino, G; Vestbo, J; Walsh, J1
Dahl, M; Ingebrigtsen, TS; Lange, P; Marott, JL; Nordestgaard, BG; Thomsen, M; Vestbo, J1
Mador, MJ; Sethi, S1
Cao, ZG; Li, JY; Li, Y; Wang, RT1
Albarrán Lozano, I; Alonso González, P; Comeche Casanova, L; Echave-Sustaeta, JM; García Luján, R; Llorente Alonso, MJ1
Donaldson, GC; Garcha, DS; George, SN; Hurst, JR; Kowlessar, BS; Mackay, AJ; Patel, AR; Singh, R; Wedzicha, JA1
Centanni, S; Di Marco, F; Pellegrino, GM; Pontiroli, AE; Repossi, AC; Roggi, MA; Santus, P; Terraneo, S; Veronelli, A1
Agusti, A; Sin, DD1
Agustí, À; Antó, JM; Basagaña, X; Beelen, R; Benet, M; Cirach, M; Dadvand, P; de Batlle, J; Ferrer, A; Ferrer, J; Garcia-Aymerich, J; Guerra, S; Hoek, G; Martinez, D; Nieuwenhuijsen, MJ; Rodriguez-Roisin, R; Sauleda, J1
Bolton, CE; Calverley, PM; Cockcroft, JR; Fuld, J; Gale, NS; Lomas, DA; MacNee, W; McEniery, CM; Miller, BE; Mohan, D; Polkey, MI; Shale, DJ; Tal-Singer, R; Wilkinson, IB1
Crişan, A; Crişan, AF; Fira-Mladinescu, O; Oancea, C; Timar, B; Tudorache, V1
Coxson, HO; Diaz, AA; Harmouche, R; Hokanson, JE; Kinney, GL; MacNee, W; Maltais, F; McDonald, ML; Rennard, S; Ross, JC; San Jose Estepar, R; Washko, GR; Wouters, EF; Young, TP; Zhou, L1
Lock-Johansson, S; Sorensen, GL; Vestbo, J1
Altintas, N; Cinarka, H; Gumus, A; Hazıroglu, M; Karatas, M; Kirbas, A; Sahin, U1
Cunningham, TJ; Ford, ES; Mannino, DM1
Chen, Y; Ji, HY; Li, CY; Ren, W; Wang, S; Zhou, Q; Zhu, CD1
Ingebrigtsen, TS; Lange, P; Marott, JL; Nordestgaard, BG; Rode, L; Vestbo, J1
Amore, C; Beume, R; Dell'Elba, G; Di Santo, A; Evangelista, V; Martelli, N; Piccoli, A; Tenor, H; Totani, L1
Furtwaengler, A; Leidy, N; Lowings, M; Mannino, DM; Martin, TR; Martin, UJ; Merrill, DD; Miller, BE; Rennard, SI; Snyder, J; Tal-Singer, R; Walsh, J1
Hanania, NA; Lavoie, K; Müllerová, H; Rennard, SI; Tal-Singer, R; Vestbo, J; Wouters, EF; Yohannes, AM1
Hurst, JR1
Kleniewska, A; Nowakowska-Świrta, E; Piotrowski, W; Walusiak-Skorupa, J; Wiszniewska, M1
Cantor, JO; Lin, YY; Ma, S; Turino, GM1
Agusti, A; Halpin, D; Martinez, FJ; Roche, N; Singh, D; Wedzicha, JA1
Barr, RG; Burke, GL; Cushman, M; Enright, PL; Jiang, R; Kronmal, RA; Margolis, HG; Newman, AB; Tracy, RP; Wang, Y1
Burghuber, OC; Cekici, L; Eickhoff, P; Geyer, K; Kiss, D; Kohansal, R; Schreder, M; Valipour, A1
Daniil, ZD; Germenis, A; Gourgoulianis, KI; Kiropoulos, TS; Kostikas, K; Koutsokera, A; Nikoulis, DJ; Papaioannou, AI; Tanou, K; Tsolaki, V1
Dentener, MA; Houwing-Duistermaat, JJ; Kotz, D; Passos, VL; Spruit, MA; Wouters, EF; Yanbaeva, DG1
Alexeeff, SE; Litonjua, AA; Mittleman, MA; Poon, A; Schwartz, J; Sparrow, D; Vokonas, PS; Wilker, EH1
Dahl, M; Nordestgaard, BG1
Holz, O; Kirsten, A; Kretschmar, G; Magnussen, H; Meyer, T; Müller, KC; Waschki, B; Watz, H1
Chen, C; Ding, J; Jiang, G; Xu, Z; Zhang, Y; Zhu, Y1
Casadio, C; Massera, F; Mineo, TC; Papalia, E; Pirondini, E; Rena, O; Turello, D1
Antoniu, SA1
Celenk, MK; Geyik, B; Maden, O; Selcuk, H; Selcuk, MT; Tüfekcioglu, O1
Sata, M1
Gao, S; Liu, Y; Ning, Q; Wang, X; Xiao, F; Xiong, Y; Xu, S; Yan, W1
del Puerto-Nevado, L; Girón-Martínez, A; Peces-Barba, G; Pérez-Rial, S1
Barnacle, H; Barnes, NC; Keene, O; Lipson, DA; Lomas, DA; Miller, BE; Tal-Singer, R; Willits, L1
Mannino, DM; Müllerova, H; Tal-Singer, R; Valvi, D2
Carter, RI; Mumford, RA; Stockley, RA; Ungurs, MJ1
Díaz, PO; Dreyse, DJ; Gaggero, BA; Lisboa, BC; Saldías, PF; Sandoval, AC1
Agustí, A; Bakke, P; Calverley, PM; Celli, B; Coxson, HO; Crim, C; Edwards, LD; Lomas, DA; MacNee, W; Mayer, RJ; Miller, BE; Rennard, SI; Silverman, EK; Tal-Singer, R; Vestbo, J; Wouters, E; Yates, JC1
Bitter, H; Cheng, DT; Cockayne, DA; Fine, JS; Hilton, H; Holz, O; Kourteva, G; Magnussen, H; Müller, KC; Pillai, SG; Ravindran, P; Sridhar, S; Visvanathan, S; Waschki, B; Watz, H1
Breyer, MK; Locantore, NW; Miller, BE; Rutten, EP; Watkins, ML; Wouters, EF1
Cavalcante, AG; Cavalcante, MM; de Bruin, PF; de Bruin, VM; Nunes, DM; Pereira, ED; Viana, CS1
Dickens, J; Duvoix, A; Haq, I; Lomas, DA; Mannino, D; Miller, B; Tal-Singer, R1
Lazovic, B1
Dahl, M; Lange, P; Nordestgaard, BG; Thomsen, M; Vestbo, J1
Akkermans, R; Heijdra, Y; Klerx, W; Lenders, JW; Scheepers, PT; Schermer, TR; van der Pouw, A; van Dijk, WD; van Weel, C1
MacNee, W1
Agustí, A; Bakke, P; Beaty, TH; Celli, B; Cho, MH; Coxson, H; Crapo, JD; Gulsvik, A; Hersh, CP; Kim, DK; Kong, X; Litonjua, A; Lomas, DA; MacNee, W; Miller, BE; Qiu, W; Rennard, S; Riley, JH; Silverman, EK; Tal-Singer, R; Vestbo, J; Wouters, E; Yates, JC1
Burgel, PR; Mannino, D1
Ford, ES; Mannino, DM; Redd, SC1
Banerjee, D; Honeybourne, D; Khair, OA1
Gan, WQ; Man, SF; Senthilselvan, A; Sin, DD1
Gan, WQ; Man, SF; Sin, DD1
Chazan, R; Karwat, K; Kościuch, J1
Anandan, CL; Fowkes, FG; Lee, AJ; Lowe, GD; Powell, JT; Rumley, A; Smith, FB; Tzoulaki, I1
Kim, JH; Kim, MS; Lee, HS; Lee, JM; Nam, BH; Song, SW; Zo, JI1
Bolaman, AZ; Cakir, A; Cildag, O; Polatli, M; Yenicerioglu, Y; Yenisey, C1
Groenewegen, KH; Hop, WC; Postma, DS; Schlösser, NJ; Wielders, PL; Wouters, EF1
Creutzberg, EC; Dentener, MA; Mercken, E; Pennings, HJ; Rijkers, GT; Wouters, EF1
Klimentova, SV; Sannikova, MV; Vakhrushev, IaM1
Dahl, M; Lange, P; Nordestgaard, BG; Tybjaerg-Hansen, A; Vestbo, J1
Bhowmik, A; Harper-Owen, R; Jeffries, DJ; Johnston, SL; Maccallum, P; Meade, TW; Message, S; Moric, I; Sanderson, G; Seemungal, T; Wedzicha, JA1

Reviews

12 review(s) available for fibrinogen and Pulmonary Disease, Chronic Obstructive

ArticleYear
Fibrinogen is a promising biomarker for chronic obstructive pulmonary disease: evidence from a meta-analysis.
    Bioscience reports, 2020, 07-31, Volume: 40, Issue:7

    Topics: Biomarkers; Fibrinogen; Humans; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Symptom Flare Up

2020
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers.
    Molecular diagnosis & therapy, 2019, Volume: 23, Issue:5

    Topics: Biomarkers; Computational Biology; Disease Susceptibility; Drug Development; Fibrinogen; Humans; Liquid Biopsy; Molecular Diagnostic Techniques; Prognosis; Pulmonary Disease, Chronic Obstructive

2019
Biomarkers in COPD.
    Clinics in chest medicine, 2014, Volume: 35, Issue:1

    Topics: Biomarkers; Fibrinogen; Humans; Inflammation; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Uteroglobin

2014
Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.
    Respiratory research, 2014, Nov-25, Volume: 15

    Topics: Animals; Biomarkers; C-Reactive Protein; Chemokines, CC; Fibrinogen; Humans; Lung; Predictive Value of Tests; Prognosis; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Uteroglobin

2014
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.
    American journal of respiratory and critical care medicine, 2016, Mar-15, Volume: 193, Issue:6

    Topics: Biomarkers; Drug Discovery; Fibrinogen; Humans; Pharmaceutical Preparations; Public-Private Sector Partnerships; Pulmonary Disease, Chronic Obstructive; United States; United States Food and Drug Administration

2016
Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease.
    Annals of the American Thoracic Society, 2016, Volume: 13 Suppl 4

    Topics: alpha 1-Antitrypsin Deficiency; Biomarkers; Desmosine; Elastin; Fibrinogen; Humans; Isodesmosine; Leukocyte Elastase; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Uteroglobin

2016
Markers of early disease and prognosis in COPD.
    International journal of chronic obstructive pulmonary disease, 2009, Volume: 4

    Topics: alpha 1-Antitrypsin Deficiency; Biomarkers; C-Reactive Protein; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Denmark; Early Diagnosis; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Hospitalization; Humans; Kaplan-Meier Estimate; Mannose-Binding Lectin; Odds Ratio; Phenotype; Predictive Value of Tests; Prognosis; Pulmonary Disease, Chronic Obstructive; Registries; Risk Assessment; Risk Factors; Severity of Illness Index

2009
Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2010, Volume: 15, Issue:2

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Biomarkers; C-Reactive Protein; Cholinergic Antagonists; Drug Therapy, Combination; Fibrinogen; Humans; Inflammation; Interleukin-6; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Receptors, Adrenergic, beta-2; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome; Tumor Necrosis Factor-alpha; Uteroglobin

2010
[Role of inflammation in the etiopathogenesis of COPD].
    Archivos de bronconeumologia, 2010, Volume: 46 Suppl 11

    Topics: Airway Remodeling; Apoptosis; Chemokines; Cytokines; Fibrinogen; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Lymphocyte Subsets; Macrophages; Models, Biological; Neutrophils; Nicotiana; Oxidative Stress; Peptide Hydrolases; Pulmonary Disease, Chronic Obstructive; Smoke

2010
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.
    Thorax, 2013, Volume: 68, Issue:7

    Topics: Biomarkers; Disease Progression; Fibrinogen; Humans; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index

2013
Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
    Annals of medicine, 2013, Volume: 45, Issue:3

    Topics: Adiponectin; Aging; Airway Remodeling; Biomarkers; C-Reactive Protein; Cachexia; Cardiovascular Diseases; CD40 Ligand; Chemokines, CC; Cytokines; Desmosine; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Isodesmosine; Lung Neoplasms; Matrix Metalloproteinases; Natriuretic Peptide, Brain; Osteoprotegerin; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Serum Amyloid A Protein; Severity of Illness Index; Telomere; Uteroglobin

2013
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
    Thorax, 2004, Volume: 59, Issue:7

    Topics: C-Reactive Protein; Cytokines; Fibrinogen; Forced Expiratory Volume; Humans; Inflammation; Leukocytes; Pulmonary Disease, Chronic Obstructive; Vital Capacity

2004

Trials

15 trial(s) available for fibrinogen and Pulmonary Disease, Chronic Obstructive

ArticleYear
Effects of Pulmonary Rehabilitation on Systemic Inflammation and Exercise Capacity in Bronchiectasis: A Randomized Controlled Trial.
    Lung, 2022, Volume: 200, Issue:3

    Topics: Bronchiectasis; Exercise Tolerance; Fibrinogen; Humans; Inflammation; Pulmonary Disease, Chronic Obstructive; Quality of Life

2022
Inflammatory responses to acute exercise during pulmonary rehabilitation in patients with COPD.
    European journal of applied physiology, 2020, Volume: 120, Issue:10

    Topics: Aged; Biomarkers; C-Reactive Protein; Exercise Therapy; Female; Fibrinogen; Humans; L-Selectin; Lung; Male; Middle Aged; Neutrophils; Pulmonary Disease, Chronic Obstructive; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor

2020
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
    Respiratory research, 2021, Apr-28, Volume: 22, Issue:1

    Topics: Aged; Biomarkers; Bronchodilator Agents; Disease Progression; Double-Blind Method; Drug Combinations; Female; Fibrinogen; Humans; Lung; Male; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Time Factors; Treatment Outcome; Up-Regulation

2021
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial.
    PloS one, 2018, Volume: 13, Issue:3

    Topics: Aged; Aged, 80 and over; Cyclopropanes; Double-Blind Method; Female; Fibrinogen; Humans; Male; Middle Aged; p38 Mitogen-Activated Protein Kinases; Pulmonary Disease, Chronic Obstructive; Pyridines; Systemic Inflammatory Response Syndrome

2018
Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
    Respiratory research, 2019, Apr-01, Volume: 20, Issue:1

    Topics: Aged; Autoantigens; Biomarkers; Cohort Studies; Collagen Type IV; Female; Fibrinogen; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; Mortality; Pilot Projects; Prognosis; Prospective Studies; Pulmonary Disease, Chronic Obstructive

2019
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.
    BMJ open respiratory research, 2019, Volume: 6, Issue:1

    Topics: Administration, Inhalation; Aged; Androstadienes; Benzyl Alcohols; Biomarkers; Bronchodilator Agents; C-Reactive Protein; Chlorobenzenes; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinogen; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Receptor for Advanced Glycation End Products; Symptom Flare Up; Treatment Outcome; Uteroglobin

2019
The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients.
    Biomarkers in medicine, 2013, Volume: 7, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Smoking

2013
[Effect of Qi Benefiting Blood Activating Method on Plasma Fibrinogen and D-dimer in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2015, Volume: 35, Issue:5

    Topics: Acute Disease; Drugs, Chinese Herbal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Humans; Plasma; Pulmonary Disease, Chronic Obstructive; Qi

2015
Air-leak management after upper lobectomy in patients with fused fissure and chronic obstructive pulmonary disease: a pilot trial comparing sealant and standard treatment.
    Interactive cardiovascular and thoracic surgery, 2009, Volume: 9, Issue:6

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drainage; Drug Combinations; Electrocoagulation; Female; Fibrinogen; Humans; Length of Stay; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Pneumonectomy; Postoperative Complications; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Surgical Stapling; Thrombin; Tissue Adhesives; Treatment Outcome

2009
An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease.
    Journal of clinical pharmacology, 2012, Volume: 52, Issue:3

    Topics: Administration, Oral; Aged; Albuterol; Androstadienes; Cyclopropanes; Double-Blind Method; Drug Combinations; Female; Fibrinogen; Fluticasone-Salmeterol Drug Combination; Humans; Male; Middle Aged; Neutrophils; p38 Mitogen-Activated Protein Kinases; Pulmonary Disease, Chronic Obstructive; Pyridines; Sputum

2012
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Biomarkers; C-Reactive Protein; Cohort Studies; Cross-Sectional Studies; Fibrinogen; Humans; Interleukin-6; Interleukin-8; Leukocyte Count; Phenotype; Pulmonary Disease, Chronic Obstructive; Smoking; Spirometry; Surveys and Questionnaires; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha

2012
Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial.
    Respiratory medicine, 2013, Volume: 107, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bronchodilator Agents; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoke; Smoking; Tars; Vital Capacity

2013
Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2012, Dec-15, Volume: 186, Issue:12

    Topics: C-Reactive Protein; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Quantitative Trait Loci; Tumor Necrosis Factor-alpha; Uteroglobin

2012
Increased systemic inflammation is a risk factor for COPD exacerbations.
    Chest, 2008, Volume: 133, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Forced Expiratory Volume; Functional Residual Capacity; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Prednisolone; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; Tumor Necrosis Factors

2008
Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study.
    Respiration; international review of thoracic diseases, 2008, Volume: 76, Issue:3

    Topics: Acute-Phase Proteins; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal; Biomarkers; C-Reactive Protein; Cachexia; Carrier Proteins; Cytokines; Double-Blind Method; Female; Fibrinogen; Humans; Infliximab; Intercellular Adhesion Molecule-1; Male; Membrane Glycoproteins; Middle Aged; Peroxidase; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Uteroglobin

2008

Other Studies

65 other study(ies) available for fibrinogen and Pulmonary Disease, Chronic Obstructive

ArticleYear
Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease.
    American journal of physiology. Lung cellular and molecular physiology, 2022, 04-01, Volume: 322, Issue:4

    Topics: Animals; Cadmium; Fibrinogen; Humans; Lung; Macrophage Activation; Mice; Pulmonary Disease, Chronic Obstructive; Toll-Like Receptor 4

2022
Fibrinogen, a Promising Marker to Evaluate Severity and Prognosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study.
    International journal of chronic obstructive pulmonary disease, 2022, Volume: 17

    Topics: Biomarkers; Emphysema; Fibrinogen; Humans; Pneumonia; Prognosis; Pulmonary Disease, Chronic Obstructive; Retrospective Studies

2022
A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease.
    Respiratory research, 2022, Sep-18, Volume: 23, Issue:1

    Topics: Cohort Studies; Community-Acquired Infections; Fibrinogen; Hospital Mortality; Humans; Interleukin-6; Pneumonia; Pulmonary Disease, Chronic Obstructive; Retrospective Studies

2022
Assessment of incidence of cerebral vascular diseases and prediction of stroke risk in chronic obstructive pulmonary disease patients using multimodal biomarkers.
    The clinical respiratory journal, 2023, Volume: 17, Issue:3

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Carotid Intima-Media Thickness; Case-Control Studies; Cerebrovascular Disorders; Creatinine; Cross-Sectional Studies; Diffusion Tensor Imaging; Female; Fibrinogen; Humans; Incidence; Interleukin-6; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Stroke; von Willebrand Factor

2023
Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment.
    International journal of chronic obstructive pulmonary disease, 2023, Volume: 18

    Topics: Fibrinogen; Heart Diseases; Humans; Prognosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Uteroglobin

2023
Blood biomarkers in chronic obstructive pulmonary disease: is there a life beyond plasma fibrinogen?
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2019, 09-01, Volume: 23, Issue:9

    Topics: Biomarkers; Eosinophils; Fibrinogen; Humans; Life; Phenotype; Plasma; Pulmonary Disease, Chronic Obstructive

2019
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
    Journal of medical virology, 2020, Volume: 92, Issue:7

    Topics: Adult; Aged; Area Under Curve; Betacoronavirus; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Complications; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; SARS-CoV-2; Sensitivity and Specificity; Severity of Illness Index; Thrombin Time

2020
Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study.
    COPD, 2020, Volume: 17, Issue:3

    Topics: Aged; Antigens, CD; C-Reactive Protein; CD11b Antigen; Cell Adhesion Molecules; Cohort Studies; Disease Progression; Female; Fibrinogen; Forced Expiratory Volume; GPI-Linked Proteins; Humans; Inflammation; L-Selectin; Leukocyte Count; Male; Middle Aged; Neutrophil Activation; Neutrophils; Physical Therapy Modalities; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires; Vital Capacity; Walk Test

2020
Analysis of Blood Biomarkers in Patients with Chronic Obstructive Pulmonary Disease (COPD) and with Asthma-COPD Overlap (ACO).
    COPD, 2020, Volume: 17, Issue:3

    Topics: Aged; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Biomarkers; C-Reactive Protein; Dyspnea; Eosinophilia; Eosinophils; Female; Fibrinogen; Forced Expiratory Volume; Humans; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Platelet Count; Pulmonary Disease, Chronic Obstructive; Vital Capacity

2020
Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta.
    PloS one, 2020, Volume: 15, Issue:6

    Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Creatinine; Cytokines; Female; Fibrinogen; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Leukocyte Count; Male; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Quality of Life; Severity of Illness Index; Uric Acid

2020
Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.
    Balkan medical journal, 2017, 05-05, Volume: 34, Issue:3

    Topics: Aged; Biomarkers; C-Reactive Protein; Disease Progression; Echocardiography; Female; Fibrinogen; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Serbia; Ventricular Dysfunction, Left; Ventricular Function, Left

2017
Predictors of Heparin Resistance Before Cardiovascular Operations in Adults.
    The Annals of thoracic surgery, 2018, Volume: 105, Issue:5

    Topics: Aged; Anticoagulants; Antithrombin III; Aortic Dissection; Cardiopulmonary Bypass; Case-Control Studies; Drug Resistance; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking

2018
Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.
    Thorax, 2018, Volume: 73, Issue:12

    Topics: Aged; Aorta; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Muscle Contraction; Muscle Weakness; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Quadriceps Muscle; Vascular Stiffness

2018
Clinical Phenotypes, Comorbidities, and Exacerbations according to Serum 25-OH Vitamin D and Plasma Fibrinogen Levels in Chronic Obstructive Pulmonary Disease.
    Journal of Korean medical science, 2019, Jul-29, Volume: 34, Issue:29

    Topics: Aged; Biomarkers; Calcifediol; Female; Fibrinogen; Forced Expiratory Volume; Humans; Male; Middle Aged; Phenotype; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Severity of Illness Index

2019
Vitamin D and Chronic Obstructive Pulmonary Disease: Biomarker Related to Outcomes.
    Journal of Korean medical science, 2019, 07-29, Volume: 34, Issue:29

    Topics: Biomarkers; Fibrinogen; Humans; Phenotype; Pulmonary Disease, Chronic Obstructive; Vitamin D; Vitamin D Deficiency

2019
Frequency of multi-dimensional COPD indices and relation with disease activity markers.
    COPD, 2013, Volume: 10, Issue:4

    Topics: Aged; Biomarkers; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Cytokines; Female; Fibrinogen; Health Status; Humans; Male; Middle Aged; Motor Activity; Nitrates; Nitrites; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Albumin; Severity of Illness Index; Spirometry; Surveys and Questionnaires

2013
The COPD Biomarker Qualification Consortium (CBQC).
    COPD, 2013, Volume: 10, Issue:3

    Topics: Biomarkers; C-Reactive Protein; Desmosine; Disease Progression; Exercise Test; Fibrinogen; Health Status; Humans; Public-Private Sector Partnerships; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Radiography; Respiratory Function Tests; Respiratory Mechanics; Severity of Illness Index; Sputum; Surveys and Questionnaires; Treatment Outcome; Uteroglobin

2013
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    JAMA, 2013, Jun-12, Volume: 309, Issue:22

    Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Biomarkers; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Forced Expiratory Volume; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Odds Ratio; Patient Admission; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk; Risk Assessment; Severity of Illness Index; Vital Capacity

2013
Systemic inflammation in predicting COPD exacerbations.
    JAMA, 2013, Jun-12, Volume: 309, Issue:22

    Topics: C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Pulmonary Disease, Chronic Obstructive

2013
Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
    Respirology (Carlton, Vic.), 2013, Volume: 18, Issue:8

    Topics: Aged; Blood Cell Count; Blood Gas Analysis; C-Reactive Protein; Case-Control Studies; Disease Progression; Female; Fibrinogen; Humans; Male; Mean Platelet Volume; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index

2013
Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study of associated variables.
    Archivos de bronconeumologia, 2013, Volume: 49, Issue:9

    Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Cytokines; Erythrocyte Indices; Female; Ferritins; Fibrinogen; Hematocrit; Hemoglobins; Humans; Inflammation; Iron; Male; Middle Aged; Prevalence; Prognosis; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Spain; Transferrin

2013
Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2013, Nov-01, Volume: 188, Issue:9

    Topics: Aged; Aged, 80 and over; Aorta; Blood Pressure; C-Reactive Protein; Cardiomyopathies; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Fibrinogen; Heart Rate; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Risk Factors; Spirometry; Sputum; Troponin T; Vascular Stiffness

2013
Physical activity impairment in depressed COPD subjects.
    Respiratory care, 2014, Volume: 59, Issue:5

    Topics: Accelerometry; Aged; Anaerobic Threshold; C-Reactive Protein; Depression; Dyspnea; Electric Impedance; Exercise Test; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Motor Activity; Nutritional Status; Obesity; Psychiatric Status Rating Scales; Pulmonary Disease, Chronic Obstructive; Quality of Life

2014
Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients.
    The European respiratory journal, 2014, Volume: 44, Issue:3

    Topics: Aged; Air Movements; Air Pollutants; Air Pollution; Biomarkers; C-Reactive Protein; Cohort Studies; Female; Fibrinogen; Forced Expiratory Volume; Hepatocyte Growth Factor; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Middle Aged; Nitrogen Dioxide; Obesity; Particulate Matter; Pulmonary Disease, Chronic Obstructive; Research Design; Smoking; Tumor Necrosis Factor-alpha

2014
Evaluating the role of inflammation in chronic airways disease: the ERICA study.
    COPD, 2014, Volume: 11, Issue:5

    Topics: Adult; Aged; Cardiovascular Diseases; Carotid Intima-Media Thickness; Exercise Test; Female; Fibrinogen; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Muscle Strength; Muscular Diseases; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Quadriceps Muscle; Respiratory Muscles; Smoking

2014
Cognitive impairment in chronic obstructive pulmonary disease.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Attention; Blood Sedimentation; C-Reactive Protein; Cognition; Cognitive Dysfunction; Female; Fibrinogen; Forced Expiratory Volume; Humans; Male; Memory Disorders; Mental Recall; Middle Aged; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires

2014
Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers.
    Academic radiology, 2014, Volume: 21, Issue:10

    Topics: Adiposity; Adult; Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Internationality; Longitudinal Studies; Male; Middle Aged; Prevalence; Pulmonary Disease, Chronic Obstructive; Radiography, Thoracic; Reproducibility of Results; Respiratory Muscles; Sensitivity and Specificity; Sex Characteristics; Sex Distribution; Subcutaneous Fat; Tomography, X-Ray Computed

2014
Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
    International journal of chronic obstructive pulmonary disease, 2015, Volume: 10

    Topics: Aged; Area Under Curve; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Disease Progression; Drug Monitoring; Female; Fibrinogen; Humans; Inflammation Mediators; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Receptors, Urokinase Plasminogen Activator; Retrospective Studies; ROC Curve; Time Factors; Treatment Outcome; Up-Regulation

2015
Inflammatory markers and mortality among US adults with obstructive lung function.
    Respirology (Carlton, Vic.), 2015, Volume: 20, Issue:4

    Topics: Adult; Age Factors; Aged; Albuminuria; Biomarkers; C-Reactive Protein; Creatinine; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Prognosis; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Spirometry; United States

2015
Fibrinogen and α1-antitrypsin in COPD exacerbations.
    Thorax, 2015, Volume: 70, Issue:11

    Topics: Aged; Alleles; alpha 1-Antitrypsin; Female; Fibrinogen; Forced Expiratory Volume; Genetic Testing; Genotype; Humans; Male; Pulmonary Disease, Chronic Obstructive; Recurrence; Retrospective Studies

2015
Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes.
    Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:1

    Topics: Aminopyridines; Animals; Benzamides; Blood Platelets; Cardiovascular Diseases; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Extracellular Traps; Fibrinogen; Humans; Leukocytes; Macrophage-1 Antigen; Mice; Microscopy, Confocal; Monocytes; Neutrophils; P-Selectin; Phosphatidylinositol 3-Kinases; Phosphodiesterase 4 Inhibitors; Phosphorylation; Platelet Adhesiveness; Pulmonary Disease, Chronic Obstructive; Risk; Thromboplastin; Thrombosis

2016
Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.
    Chest, 2016, Volume: 149, Issue:4

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Chemokines, CC; Cohort Studies; Depression; Depressive Disorder; Disease Progression; Dyspnea; Exercise Test; Fatigue; Female; Fibrinogen; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Sex Factors; Stroke; Uteroglobin

2016
Precision Medicine in Chronic Obstructive Pulmonary Disease.
    American journal of respiratory and critical care medicine, 2016, Mar-15, Volume: 193, Issue:6

    Topics: Drug Discovery; Fibrinogen; Humans; Public-Private Sector Partnerships; Pulmonary Disease, Chronic Obstructive

2016
Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Journal of occupational health, 2016, Jul-22, Volume: 58, Issue:4

    Topics: Adult; Aged; Asthma, Occupational; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Humans; Interleukin-1beta; Interleukin-6; Male; Matrix Metalloproteinase 9; Middle Aged; Occupational Diseases; Occupational Exposure; Pulmonary Disease, Chronic Obstructive; Smoking; Sputum; Tumor Necrosis Factor-alpha

2016
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    American journal of respiratory and critical care medicine, 2016, 09-01, Volume: 194, Issue:5

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Biomarkers; Bronchodilator Agents; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Fibrinogen; Forced Expiratory Volume; Humans; Muscarinic Antagonists; Phenotype; Precision Medicine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Severity of Illness Index

2016
Inflammatory markers and longitudinal lung function decline in the elderly.
    American journal of epidemiology, 2008, Sep-15, Volume: 168, Issue:6

    Topics: Aged; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Forced Expiratory Volume; Geriatric Assessment; Humans; Logistic Models; Longitudinal Studies; Lung Volume Measurements; Male; Multicenter Studies as Topic; Pulmonary Disease, Chronic Obstructive; Spirometry

2008
Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2008, Dec-15, Volume: 178, Issue:12

    Topics: Adult; Aged; Biomarkers; Blood Flow Velocity; Brachial Artery; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Forced Expiratory Volume; Humans; Interleukin-6; Male; Middle Aged; Prognosis; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Ultrasonography; Vasodilation

2008
Clinical, functional and biochemical changes during recovery from COPD exacerbations.
    Respiratory medicine, 2009, Volume: 103, Issue:6

    Topics: Aged; Biomarkers; C-Reactive Protein; Disease Progression; Dyspnea; Female; Fibrinogen; Forced Expiratory Volume; Hospitalization; Humans; Interleukin-6; Male; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Severity of Illness Index; Time Factors; Tumor Necrosis Factors; Vital Capacity

2009
IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.
    BMC medical genetics, 2009, Mar-09, Volume: 10

    Topics: Adult; Aged; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Genome-Wide Association Study; Genotype; Haplotypes; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive

2009
Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men.
    Atherosclerosis, 2009, Volume: 206, Issue:2

    Topics: Aged; Aging; Asthma; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Respiration Disorders; Vascular Cell Adhesion Molecule-1

2009
The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.
    Chest, 2009, Volume: 136, Issue:4

    Topics: Aged; Biomarkers; Bronchitis; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Pulmonary Disease, Chronic Obstructive; Regression Analysis

2009
Surgical management of secondary spontaneous pneumothorax in elderly patients with chronic obstructive pulmonary disease: retrospective study of 107 cases.
    The Thoracic and cardiovascular surgeon, 2009, Volume: 57, Issue:6

    Topics: Aged; Aged, 80 and over; Evidence-Based Medicine; Female; Fibrinogen; Hospital Mortality; Humans; Injections; Logistic Models; Male; Middle Aged; Patient Selection; Pleurodesis; Pneumothorax; Pulmonary Disease, Chronic Obstructive; Reoperation; Retrospective Studies; Risk Assessment; Risk Factors; Thoracic Surgery, Video-Assisted; Thoracotomy; Time Factors; Treatment Outcome

2009
Documentation of impaired coronary blood flow in chronic obstructive pulmonary disease patients.
    Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:2

    Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Angiography; Coronary Circulation; Coronary Vessels; Cross-Sectional Studies; Female; Fibrinogen; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index

2010
Cardiovascular disease and chronic obstructive pulmonary disease.
    Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:2

    Topics: Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Circulation; Coronary Vessels; Fibrinogen; Forced Expiratory Volume; Humans; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index

2010
The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway.
    Biochemical and biophysical research communications, 2010, May-28, Volume: 396, Issue:2

    Topics: Aged; Bronchoalveolar Lavage Fluid; Female; Fibrinogen; Gene Knockdown Techniques; Humans; Lipopolysaccharides; Macrophage Activation; Macrophages, Alveolar; Male; Middle Aged; p38 Mitogen-Activated Protein Kinases; Pulmonary Disease, Chronic Obstructive; Thromboplastin

2010
Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts.
    International journal of chronic obstructive pulmonary disease, 2012, Volume: 7

    Topics: Aged; Aged, 80 and over; Biomarkers; Cohort Studies; Female; Fibrinogen; Hospitalization; Humans; Inflammation Mediators; Linear Models; Logistic Models; Lung; Male; Middle Aged; Odds Ratio; Prognosis; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Severity of Illness Index; Spirometry; Time Factors; United States; Up-Regulation

2012
Fibrinogen, COPD and mortality in a nationally representative U.S. cohort.
    COPD, 2012, Volume: 9, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fibrinogen; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Nutrition Surveys; Prognosis; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; United States

2012
Aα-Val360: a marker of neutrophil elastase and COPD disease activity.
    The European respiratory journal, 2013, Volume: 41, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fibrinogen; Humans; Leukocyte Elastase; Male; Middle Aged; Peptide Fragments; Pulmonary Disease, Chronic Obstructive

2013
[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Revista medica de Chile, 2012, Volume: 140, Issue:1

    Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cohort Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Leukocyte Count; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Sputum

2012
Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Acute-Phase Proteins; Aged; Biomarkers; Cohort Studies; Comorbidity; Female; Fibrinogen; Forced Expiratory Volume; Granulocyte Colony-Stimulating Factor; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-3; Lipocalin-2; Lipocalins; Male; Metabolic Syndrome; Multivariate Analysis; Proto-Oncogene Proteins; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Recombinant Fusion Proteins; Regression Analysis; S100 Proteins; S100A12 Protein; Smoking; Transforming Growth Factor alpha

2012
Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
    European journal of clinical investigation, 2012, Volume: 42, Issue:9

    Topics: Adipokines; Biomarkers; Body Mass Index; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Sex Factors

2012
Restless legs syndrome, sleep impairment, and fatigue in chronic obstructive pulmonary disease.
    Sleep medicine, 2012, Volume: 13, Issue:7

    Topics: Age Factors; Aged; Comorbidity; Creatinine; Cross-Sectional Studies; Depression; Fatigue; Ferritins; Fibrinogen; Hemoglobins; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pulmonary Disease, Chronic Obstructive; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders; Statistics, Nonparametric

2012
Correlation of CRP and serum level of fibrinogen with severity of disease in chronic obstructive pulmonary disease patients.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2012, Volume: 66, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive

2012
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2012, Nov-15, Volume: 186, Issue:10

    Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Forced Expiratory Volume; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk; Vital Capacity

2012
Systemic inflammation in patients with chronic obstructive pulmonary disease: one size no longer fits all!
    American journal of respiratory and critical care medicine, 2012, Nov-15, Volume: 186, Issue:10

    Topics: C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation Mediators; Leukocyte Count; Male; Pulmonary Disease, Chronic Obstructive

2012
Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination.
    The American journal of medicine, 2003, Jun-15, Volume: 114, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Nutrition Surveys; Pulmonary Disease, Chronic Obstructive; Risk Factors; Severity of Illness Index; Smoking; Spirometry; Surveys and Questionnaires; United States

2003
Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD.
    The European respiratory journal, 2004, Volume: 23, Issue:5

    Topics: Aged; Bacteria; Blood Viscosity; Bronchi; Fibrinogen; Health Status; Humans; Inflammation Mediators; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Sputum

2004
The interactions between cigarette smoking and reduced lung function on systemic inflammation.
    Chest, 2005, Volume: 127, Issue:2

    Topics: Adult; Aged; C-Reactive Protein; Causality; Cotinine; Cross-Sectional Studies; Female; Fibrinogen; Forced Expiratory Volume; Health Surveys; Humans; Leukocyte Count; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Count; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Statistics as Topic; Systemic Inflammatory Response Syndrome; United States

2005
[Is microembolism present and is it important element of COPD exacerbation?].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2005, Volume: 18, Issue:106

    Topics: Aged; Blood Gas Analysis; Case-Control Studies; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Platelet Count; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Risk Factors; Severity of Illness Index; Spirometry; Surveys and Questionnaires

2005
Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.
    Journal of vascular surgery, 2006, Volume: 43, Issue:3

    Topics: Aged; alpha-2-Antiplasmin; Aortic Aneurysm, Abdominal; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Forced Expiratory Volume; Hemostasis; Humans; Inflammation; Lung; Male; Pulmonary Disease, Chronic Obstructive; Smoking; Spirometry; Surveys and Questionnaires; Ultrasonography; Vital Capacity

2006
Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection.
    The Annals of thoracic surgery, 2006, Volume: 81, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bronchial Fistula; Bronchial Spasm; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Empyema, Pleural; Female; Fibrinogen; Fistula; Humans; Intraoperative Period; Life Tables; Lung Neoplasms; Male; Middle Aged; Pleural Diseases; Pneumonectomy; Pneumonia; Postoperative Complications; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Retrospective Studies; Risk; Sex Factors; Smoking; Sputum; Survival Analysis; Survival Rate

2006
Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
    Journal of thrombosis and thrombolysis, 2008, Volume: 26, Issue:2

    Topics: Aged; Albuminuria; Biomarkers; Blood Gas Analysis; Case-Control Studies; Cross-Sectional Studies; Endothelium, Vascular; Fibrinogen; Humans; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Smoking; Spirometry; Up-Regulation; von Willebrand Factor

2008
[The clinico-functional characteristics of the pancreas in chronic obstructive pulmonary disease].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:6

    Topics: Adult; Aged; Amylases; Blood Glucose; Erythrocyte Count; Erythrocytes; Female; Fibrinogen; Hemoglobins; Humans; Insulin; Lipase; Male; Microcirculation; Middle Aged; Pancreas; Pancreatic Diseases; Prothrombin; Pulmonary Disease, Chronic Obstructive; Ultrasonography

2007
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2001, Sep-15, Volume: 164, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Body Mass Index; Bronchitis; Chronic Disease; Data Interpretation, Statistical; Denmark; Female; Fibrinogen; Forced Expiratory Volume; Hospitalization; Humans; Linear Models; Lung; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk; Risk Factors; Smoking

2001
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2001, Nov-01, Volume: 164, Issue:9

    Topics: Aged; Common Cold; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; London; Male; Medical Records; Polymerase Chain Reaction; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Mechanics; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Risk; Statistics, Nonparametric; Virus Diseases

2001